HER 2(+) new therapeutic alternatives in HER 2(+) breast cancer, Pregnancy in breast cancer, and Are we ready to individualize chemotherapy by breast cancer subtype?
HER 2(+) new therapeutic alternatives in HER 2(+) breast cancer, Pregnancy in breast cancer, and Are we ready to individualize chemotherapy by breast cancer subtype?
- 2015
Washington Cancer Institute
Washington Cancer Institute